Assessing clinical and spirometric control and the intensity of the inflammatory process in asthma. |
J Pediatr (Rio J) |
|
CR. Andrade, JM. Chatkin, PA. Camargos |
One year follow-up of patients after successful helicobacter pylori eradication therapy. |
J. Physiol. Paris |
|
A. Vincze, O. Karádi, B. Hunyady, F. Pakodi, G. Suto, G. Mózsik |
Malondialdehyde in exhaled breath condensate and urine as a biomarker of air pollution induced oxidative stress. |
J Expo Sci Environ Epidemiol |
|
J. Gong, T. Zhu, H. Kipen, G. Wang, M. Hu, P. Ohman-Strickland, SE. Lu, L. Zhang, Y. Wang, P. Zhu, DQ. Rich, SR. Diehl, W. Huang, JJ. Zhang |
The efficacy of single-high dose inhaled corticosteroid versus oral prednisone treatment on exhaled leukotriene and 8-isoprostane levels in mild to moderate asthmatic children with asthma exacerbation. |
Allergol Immunopathol (Madr) |
|
O. Keskin, U. Uluca, M. Keskin, B. Gogebakan, E. Kucukosmanoglu, MY. Ozkars, S. Kul, H. Bayram, Y. Coskun |
The National Exposure Registry: procedures for establishing a registry of persons environmentally exposed to hazardous substances. |
Toxicol Ind Health |
|
JR. Burg, GL. Gist |
Attenuation of methane and volatile organic compounds in landfill soil covers. |
J. Environ. Qual. |
|
C. Scheutz, H. Mosbaek, P. Kjeldsen |
The effects of age on exhaled breath nitric oxide levels. |
Lung |
|
RR. Haight, RL. Gordon, SM. Brooks |
Inflammatory response to sputum induction measured by exhaled markers. |
Respiration |
|
A. Antczak, SA. Kharitonov, P. Montuschi, P. Gorski, PJ. Barnes |
[Helicobacter pylori infection: Review and practice]. |
Presse Med |
|
F. Mégraud |
Exposure reconstruction for reducing uncertainty in risk assessment: example using MTBE biomarkers and a simple pharmacokinetic model. |
Biomarkers |
|
JD. Pleil, D. Kim, JD. Prah, SM. Rappaport |